miR-193a和IL17RD在甲状腺癌中的表达及其临床意义-现代医学

miR-193a和IL17RD在甲状腺癌中的表达及其临床意义

单位：宜宾市第二人民医院乳腺甲状腺科, 四川宜宾 644000

分类号：R736.1

出版年·卷·期（页码）：2018·46·第七期（765-769）

摘要：

目的：探讨微小RNA-193a （miR-193a）和白细胞介素17受体D （IL17RD）在甲状腺癌组织中的表达及其与甲状腺癌临床病理特征的关系。方法：收集经病理学确诊为甲状腺癌（88例）、甲状腺腺瘤（31例）、桥本甲状腺炎（26例）、结节性甲状腺肿（12例）及正常甲状腺（18例）的冷冻组织，采用蛋白免疫印迹、实时定量PCR分析组织中miR-193a和IL17RD mRNA及其蛋白表达情况，并分析它们与甲状腺癌临床病理特征的关系。结果：与正常甲状腺组织相比，桥本甲状腺炎、甲状腺腺瘤、甲状腺癌组织中miR-193a表达水平显著降低，而IL17RD mRNA和蛋白表达显著增加（均P<0.05）。甲状腺癌组织中miR-193a和IL17RD蛋白表达水平与肿瘤大小、临床分期、组织学分化程度及淋巴结转移等临床特征有关（均P<0.05）。miR-193a与IL17RD mRNA和蛋白表达均呈明显负相关（P<0.05）。结论：甲状腺癌组织中miR-193a和IL17RD的表达与肿瘤大小、临床分期、组织学分化、淋巴结转移等特征有关，miR-193a可能通过靶向IL17RD参与甲状腺癌的发生及进展。

Objective: To investigate the expression of miR-193a and IL17RD in thyroid carcinoma, and analyze the relationship with clinicopathological features of thyroid carcinoma. Methods: The frozen tissues from pathologically confirmed thyroid cancer (88 cases), thyroid adenoma (31 cases), Hashimoto's thyroiditis (26 cases), nodular goiter (12 cases) and normal thyroid gland (18 cases) were collected. Western blot, real-time quantitative PCR were used to analyze the expression of miR-193a and IL17RD in the tissues. The relationship with clinicopathological features of thyroid carcinoma was explored. Results: Compared with normal thyroid tissue, the expression of miR-193a in Hashimoto's thyroiditis, thyroid adenoma and thyroid cancer tissue were significantly decreased, while the expression of IL17RD was significantly increased (all P<0.05).The expression of miR-193a and IL17RD protein in thyroid cancer tissue were related to the clinical features such as tumor size,clinical stage,histological grade and lymph node metastasis(P<0.05).There was a significant negative correlation between the expression of miR-193a and IL17RD (P<0.05). Conclusion: The expressionof miR-193a and IL17RD in thyroid cancer tissues are related to tumor size,clinical stage,histological differentiation, and lymph node metastasis.miR-193a may be involved in the progression of thyroid cancer by targeting IL17RD.

参考文献：

[1] 曹一鸣.甲状腺癌的DNA甲基化研究进展[J].中国癌症杂志,2017,27(4):304-311.
[2] 尹凌帝,孙倩,孙明,等.人类癌症中长链非编码RNA与miRNA相互作用的研究进展[J].临床肿瘤学杂志,2014(7):662-666.
[3] TAHIRI A,LEIVONEN S K,LVDERS T,et al.Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors[J].Carcinogenesis,2014,35(1):76-85.
[4] HORI S,WADHWA K,PISUPATI V,et al.Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer[J].Int J Cancer,2017,140(8):1881-1887.
[5] 黄韬,胡丽丽,周军.难治性分化型甲状腺癌的研究进展[J].东南大学学报(医学版),2017,36(5):876-881.
[6] 单学赟,孙乃同,王纯斌.微小RNA与多发性骨髓瘤诊治的研究进展[J].现代医学,2017,45(9):1380-1383.
[7] 戴文斌.微小RNA与甲状腺癌的关系及其研究进展[J].中国医药导报,2014,11(3):165-168.
[8] 陈旭,徐燕梅,张露萍,等.非小细胞肺癌放疗敏感性miRNAs的生物信息学筛选[J].中华肺部疾病杂志(电子版),2016,9(2):131-134.
[9] 贾亚旭,王成,张春妮.血清miR-193a-3p,miR-337-5p和miR-483-5p在食管鳞状细胞癌诊断和预后中的应用[J].现代检验医学杂志,2017,32(2):5-9.
[10] 李必一,王若雨,赵勇.IL-17在肿瘤发生发展中的作用及其临床意义[J].中国医药生物技术,2016,12(1):64-68.
[11] UMSTEAD M K,XIONG J,QI Q,et al.Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling[J].Oncotarget,2017,8(17):28359-28367.
[12] REN Y,CHENG L,RONG Z,et al.HSef potentiates EGF-mediated MATK signaling through affecting EGFR trafficking and degradation[J].Cell Signal,2008,20(3):518-533.
[13] MURPHY T,DARBY S,MATHERS M E,et al.Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype[J].J Pathol,2010,220(4):452-460.
[14] PEKOW J,MECKEL K,DOUGHERTY U,et al.miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through up-regulation of IL17RD[J].Clin Cancer Res,2017,23(17):5281-5291.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录